Today: 9 June 2026
SAP stock jumps on Wells Fargo “top platform” call as Jan 29 earnings near
10 January 2026
1 min read

SAP stock jumps on Wells Fargo “top platform” call as Jan 29 earnings near

FRANKFURT, Jan 10, 2026, 20:23 CET — The market has now closed for the day.

  • SAP shares climbed 2.8% in Frankfurt on Friday, outstripping gains across the wider German market.
  • A Wells Fargo software note singled out SAP as a 2026 “top platform” pick, citing trends in cloud and AI spending.
  • Upcoming catalysts to watch: U.S. inflation figures on Jan. 13 and SAP’s quarterly earnings report on Jan. 29.

SAP shares gained 2.8% on Friday, pushing higher after a rocky start to the year. Investors responded to a new Wall Street note that ranked the German software giant near the top of a 2026 software outlook.

This shift is significant as SAP’s next major update is just around the corner. The company will release its fourth-quarter and full-year 2025 results on Jan. 29, with a management call and press conference scheduled for later that morning.

Wells Fargo analysts, led by Michael Turrin, surveyed 100 enterprise IT executives and found steady demand for cloud services alongside a growing focus on generative AI — the technology that generates text, images, or code. They singled out SAP as their “top platform pick for 2026.” According to the note, cloud spending is climbing “by roughly 5%,” outpacing overall IT budgets, which are “closer to 2%.” TipRanks

A separate summary on the same topic highlighted that artificial intelligence will continue to lead software performance into 2026, with spending moving toward infrastructure, major platforms, and tools for building AI systems. It specifically mentioned SAP alongside Oracle.

In Frankfurt on Friday, SAP shares fluctuated between 206.00 and 214.25 euros before closing at 212.35. The stock hovered close to a key resistance near 215 euros, while the 200-euro mark remains a nearby support level. Its 52-week trading range stretches from 199.60 to 283.50 euros, per .

The broader mood lent support. Germany’s DE40 index gained 0.53% on Jan. 9, as investors leaned into risk despite staying cautious about rates and inflation data.

During U.S. trading, SAP’s ADRs climbed to $247.11, marking a roughly 2.6% increase from the previous close, after briefly reaching $248.51 earlier in the session.

SAP’s results on Jan. 29 will refocus attention on core metrics: cloud revenue growth, customer migration speed, operating margin, and free cash flow. Investors are keen to hear how much of the current AI buzz actually translates into billable products rather than just pilot projects.

But the scenario cuts both ways. Should corporate tech budgets shrink or clients delay large enterprise-resource-planning (ERP) projects — software essential for finance, HR, and supply chains — SAP’s cloud growth could slow sharply. A fresh rise in bond yields would also put software valuations under pressure.

Investors are expected to focus on macroeconomic and interest rate signals ahead of SAP’s earnings. The U.S. consumer price index for December 2025 drops Jan. 13, followed by euro-area inflation data on Jan. 19. The ECB’s next policy meeting is scheduled for early February. SAP’s next major event is its earnings report on Jan. 29.

Stock Market Today

  • Constant and Constant Advises Piraeus Bank on Safe Bulkers Euronext Athens Dual Listing
    June 9, 2026, 9:51 AM EDT. Constant and Constant Greece and UK firm TLT advised Piraeus Bank on the dual listing of Safe Bulkers, Inc. on Euronext Athens, marking the first Greek shipping company listed in New York to also trade on Athens' exchange. Safe Bulkers, a marine dry bulk carrier with 45 vessels, is now accessible to both U.S. and Greek investors. The legal teams led cross-border due diligence covering loan facilities, guarantees, and fleet agreements to ensure compliance. This move is expected to pave the way for similar listings, enhancing Greece's capital markets. Safe Bulkers' CFO praised the firms for precise, detailed legal support throughout the complex process.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Previous Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Next Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

Go toTop